Home / COLQ Knockout Cell Lines

COLQ Knockout Cell Lines

Gene: COLQ

Official Full Name: collagen like tail subunit of asymmetric acetylcholinesteraseprovided by HGNC

Gene Summary: This gene encodes the subunit of a collagen-like molecule associated with acetylcholinesterase in skeletal muscle. Each molecule is composed of three identical subunits. Each subunit contains a proline-rich attachment domain (PRAD) that binds an acetylcholinesterase tetramer to anchor the catalytic subunit of the enzyme to the basal lamina. Mutations in this gene are associated with endplate acetylcholinesterase deficiency. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO34270 COLQ Knockout cell line (HCT 116) Human COLQ 1:2~1:4 Negative Online Inquiry

Background

COLQ Gene Knockout Cell Lines are advanced biological research tools designed to facilitate the study of COLQ gene functions, which are critical in the formation and function of neuromuscular junctions. These bespoke cell lines have been engineered using CRISPR-Cas9 gene editing technology to produce knockout variants where the COLQ gene is completely disrupted. This allows for an unparalleled examination of the gene’s role in muscle innervation and related pathologies, especially those involving congenital myasthenic syndromes.

The key mechanism underlying these knockout cell lines lies in their ability to mimic specific disease states by removing functional COLQ gene expression. As a result, researchers can observe the effects on neuromuscular transmission, synaptic development, and overall muscle physiology. This is invaluable for elucidating the molecular pathways that lead to muscle dysfunction, providing insights into potential therapeutic targets.

The scientific importance of COLQ Gene Knockout Cell Lines cannot be overstated; they serve as a cornerstone for both basic research into neuromuscular physiology and preclinical studies aimed at developing intervention strategies for related disorders. By studying the dynamics of these engineered cells, researchers can test hypotheses regarding COLQ's interaction with other proteins or molecules, significantly enhancing our understanding of neuromuscular diseases.

Compared to traditional models, such as wild-type cell lines or animal models, COLQ Gene Knockout Cell Lines offer distinct advantages, including higher reproducibility, ease of use in molecular assays, and reduced ethical concerns associated with animal research. Their specificity also allows for focused studies that yield more relevant data for drug development and gene therapy experiments.

For researchers and clinicians, the value of COLQ Gene Knockout Cell Lines lies in their ability to provide clear, actionable insights into the mechanisms of neuromuscular diseases. They represent a powerful platform for innovation in treatment strategies, ultimately leading to improved patient outcomes.

Our company brings extensive expertise in genetic engineering and biological product development, ensuring that COLQ Gene Knockout Cell Lines are produced with high standards of quality and reliability, empowering researchers in their quest for scientific advancement.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.